Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
Systemic mastocytosis (SM) is a rare neoplasm resulting from extracutaneous infiltration of clonal mast cells (MC). The clinical features of SM are very heterogenous and treatment should be highly individualized. Up to 40% of all SM cases can be associated with another hematological neoplasm, most f...
Guardado en:
Autores principales: | Mariarita Sciumè, Giusy Ceparano, Cristina Eller-Vainicher, Sonia Fabris, Silvia Lonati, Giorgio Alberto Croci, Luca Baldini, Federica Irene Grifoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d61f120879b34964acba0336c9dd2af4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA methylation profile in patients with indolent systemic mastocytosis
por: Aleksandra Górska, et al.
Publicado: (2021) -
Novel approaches to treating advanced systemic mastocytosis
por: Gilreath JA, et al.
Publicado: (2019) -
Precision Medicine in Systemic Mastocytosis
por: Maura Nicolosi, et al.
Publicado: (2021) -
Cardiac complications in a patient affected by systemic mastocytosis and primitive myelofibrosis: A case report
por: Marianna Suppa, et al.
Publicado: (2021) -
Morphological Features and KIT Receptor Expression in Canine Cutaneous Mast Cell Tumor and Systemic Mastocytosis / Morfološke Karakteristike I Ekspresija KIT Receptora Kod Kutanih Mastocitoma I Sistemske Mastocitoze Pasa
por: Marinković Darko, et al.
Publicado: (2015)